March 2007
Health (Time Inc.);Mar2007, Vol. 21 Issue 2, p98
The article presents question and answers related to personal finance. One person asks whether he should ask his doctor for a generic drug instead of a more expensive brand name drug when he needs a prescription. He is advised that he should since drug effectiveness experts have found that generics can be used effectively to treat most common conditions that require medication.


Related Articles

  • Slash your health care spending. Ashford, Kate // All You;2/22/2013, Vol. 10 Issue 2, p101 

    The article offers suggestions to control the spending on health care. It is recommended to ask for discounts on various medical therapy services. Use of generic medicines that have same active ingredient as that of brand-name medicines at a low price is also suggested. It also advises to ask...

  • Congress appeals to FDA to curb GATT's volatility. Rankin, Ken // Drug Store News;5/22/95, Vol. 17 Issue 7, p9 

    Focuses on letter sent by a bipartisan group of senators to Food and Drug Administration (FDA) Commissioner David Kessler, warning of the possible effect of the General Agreement on Tariffs and Trade (GATT) on generic introductions and cost of prescription drugs. Issue over the GATT provision...

  • Finding the win--win: Issues to consider when undertaking brand substitution. Carroll, Peter R. // Australian Journal of Pharmacy;Mar2011, Vol. 92 Issue 1090, p70 

    The article presents an overview of the introduction of the generic alternatives to original brand medicines in Australia. It notes that the introduction has reduced the amount the government has to pay for medicines under the Pharmaceutical Benefits Scheme (PBS). Furthermore, the significant...

  • Some Medicare patients might save by swapping drugs.  // Journal of Business (10756124);9/26/2013, Vol. 28 Issue 20, pB8 

    The article reports on the study led by the University of California, Los Angeles (UCLA) published in the "Journal of General Internal Medicine," which suggests that substituting brand name therapeutics with less expensive counterparts with similar effect can help Medicare patient save money.

  • ENTRY FORMAT.  // Monthly Prescribing Reference;Feb2013, Vol. 29 Issue 2, Special section pA-12 

    The article offers information on the entry format of pharmaceuticals. It informs that the therapeutic and the chemical class of the drug should be listed in italics. It highlights that the name of the manufacturer must be included in the format to provide accessibility for more medial...

  • ENTRY FORMAT.  // MPR - Urologists' Edition;Spring/Summer2012, Vol. 9 Issue 1, pA.13 

    The article offers information on the entry format for drug literatures. It notes that the chemical and therapeutic class of the drug should be listed in italics. It adds that the name of the manufacturer must be included in the format to provide accessibility for more medial information....

  • Who's winning NTI substitution war--brands or generics? Epstein, Debbie // Drug Topics;9/15/97, Vol. 141 Issue 18, p70 

    Focuses on the battle over generic substitution for narrow therapeutic index (NTI) drugs in the United States. Information on the state which has adopted regulations against NTI substitution; Comments from Charles M. Mayr, director of corporate communications for Barr Laboratories Incorporated;...

  • NHS charges are a mess, say MPs. Cole, Andrew // BMJ: British Medical Journal (International Edition);7/22/2006, Vol. 333 Issue 7560, p163 

    The author reports that Great Britain's House of Commons Health Select Committee has recommended a complete reassessment of the system of charging for health services that may include eliminating prescription charges. The exemptions system that is supposed to be based on income actually exempts...

  • NHS pays too much for branded drugs. Mayor, Susan // BMJ: British Medical Journal (International Edition);2/24/2007, Vol. 334 Issue 7590, p383 

    The article presents the results of a British government report. The report, which was from the Office of Fair Trading, a body that protects consumers' interests in the United Kingdom, found that health services in the United Kingdom are overpaying approximately $980 million a year for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics